The Retail Health Bonanza: When Weight Loss Meets Big Business As America's obesity epidemic continues to worsen, a new market is emerging that puts retailers at the forefront of a lucrative industry.
The shift towards direct to consumer GLP 1 prescriptions has created an opportunity for retail giants like Walmart, Costco, and Amazon to tap into a growing demand for obesity treatment.
Behind this trend lies a complex web of economics and consumer behavior. As employers increasingly drop coverage for GLP 1 drugs, patients are being nudged towards DTC programs that offer discounts and loyalty rewards.